论文信息 - A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial - 字舞流文

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

T. Ziemssen | N. Tubridy | J. Frederiksen | J. de Sá | A. Landtblom | A. Carrá | O. Heinzlef | O. Bajenaru | K. Karageorgiou | A. Edland | N. de Klippel | Rafael H. Lander Delgado | M. A. Macías Islas | Y. Gilgun-Sherki